FFCP PHASE1:Mm9::chr1:39495912..39495928,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr1:39495912..39495928,-|id=chr1:39495912..39495928,-|ontology_enrichment_celltype=CL:0000115!8.42e-10!1;CL:0000213!8.42e-10!1;CL:0002078!8.42e-10!1;CL:0002262!8.42e-10!1;CL:1000398!8.42e-10!1;CL:0000355!1.79e-09!9|ontology_enrichment_celltype_v019_2=CL:0000355,4.50e-13,9|ontology_enrichment_disease=DOID:0060100!4.66e-27!3;DOID:4045!4.66e-27!3;DOID:0050686!6.75e-14!6|ontology_enrichment_disease_v019_2=DOID:0060100,1.58e-37,3;DOID:4045,1.58e-37,3;DOID:0050686,3.24e-19,6|ontology_enrichment_uberon=UBERON:0001044!5.62e-10!1;UBERON:0001736!5.62e-10!1;UBERON:0003293!5.62e-10!1;UBERON:0003294!5.62e-10!1;UBERON:0010047!5.62e-10!1;UBERON:0001829!5.62e-10!1;UBERON:0000167!5.62e-10!1;UBERON:0006298!5.62e-10!1;UBERON:0000353!8.42e-10!1;UBERON:0003497!8.42e-10!1;UBERON:0003909!8.42e-10!1;UBERON:0003835!8.42e-10!1;UBERON:0003513!8.42e-10!1;UBERON:0001281!8.42e-10!1;UBERON:0001280!8.42e-10!1;UBERON:0004647!8.42e-10!1;UBERON:0001134!1.79e-09!9;UBERON:0002036!1.79e-09!9;UBERON:0002385!1.79e-09!9;UBERON:0000486!1.79e-09!9;UBERON:0001015!1.79e-09!9;UBERON:0004290!1.79e-09!9;UBERON:0003082!1.79e-09!9;UBERON:0000914!1.32e-08!17;UBERON:0000383!1.39e-08!10;UBERON:0002329!7.44e-08!11;UBERON:0003077!7.44e-08!11;UBERON:0003059!7.44e-08!11;UBERON:0007282!7.44e-08!11;UBERON:0009618!7.44e-08!11;UBERON:0007285!7.44e-08!11|ontology_enrichment_uberon_v019_2=UBERON:0001044,2.06e-13,1;UBERON:0001736,2.06e-13,1;UBERON:0003293,2.06e-13,1;UBERON:0003294,2.06e-13,1;UBERON:0001829,2.06e-13,1;UBERON:0010047,2.06e-13,1;UBERON:0000167,2.06e-13,1;UBERON:0006298,2.06e-13,1;UBERON:0001134,4.50e-13,9;UBERON:0002036,4.50e-13,9;UBERON:0002385,4.50e-13,9;UBERON:0000486,4.50e-13,9;UBERON:0007503,4.50e-13,9;UBERON:0001015,4.50e-13,9;UBERON:0002329,4.50e-13,9;UBERON:0003082,4.50e-13,9;UBERON:0003059,4.50e-13,9;UBERON:0007282,4.50e-13,9;UBERON:0004290,4.50e-13,9;UBERON:0009618,4.50e-13,9;UBERON:0000383,7.70e-12,10;UBERON:0007524,7.91e-11,11;UBERON:0003077,7.91e-11,11;UBERON:0007285,7.91e-11,11;UBERON:0000165,2.35e-07,2;UBERON:0000166,2.35e-07,2;UBERON:0000930,2.35e-07,2|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.27797446105362,7.813353445238,4.18818995179039,21.7645650571475,10.9287277593351,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201683524623343,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24267862617385,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr1:39495912..39495928,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr1:39495912..39495928,- | |||
|description=CAGE_peak_at_chr1:39495912..39495928,- | |||
|id=chr1:39495912..39495928,- | |||
|ontology_enrichment_celltype=CL:0000115!8.42e-10!1;CL:0000213!8.42e-10!1;CL:0002078!8.42e-10!1;CL:0002262!8.42e-10!1;CL:1000398!8.42e-10!1;CL:0000355!1.79e-09!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.50e-13,9 | |||
|ontology_enrichment_disease=DOID:0060100!4.66e-27!3;DOID:4045!4.66e-27!3;DOID:0050686!6.75e-14!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.58e-37,3;DOID:4045,1.58e-37,3;DOID:0050686,3.24e-19,6 | |||
|ontology_enrichment_uberon=UBERON:0001044!5.62e-10!1;UBERON:0001736!5.62e-10!1;UBERON:0003293!5.62e-10!1;UBERON:0003294!5.62e-10!1;UBERON:0010047!5.62e-10!1;UBERON:0001829!5.62e-10!1;UBERON:0000167!5.62e-10!1;UBERON:0006298!5.62e-10!1;UBERON:0000353!8.42e-10!1;UBERON:0003497!8.42e-10!1;UBERON:0003909!8.42e-10!1;UBERON:0003835!8.42e-10!1;UBERON:0003513!8.42e-10!1;UBERON:0001281!8.42e-10!1;UBERON:0001280!8.42e-10!1;UBERON:0004647!8.42e-10!1;UBERON:0001134!1.79e-09!9;UBERON:0002036!1.79e-09!9;UBERON:0002385!1.79e-09!9;UBERON:0000486!1.79e-09!9;UBERON:0001015!1.79e-09!9;UBERON:0004290!1.79e-09!9;UBERON:0003082!1.79e-09!9;UBERON:0000914!1.32e-08!17;UBERON:0000383!1.39e-08!10;UBERON:0002329!7.44e-08!11;UBERON:0003077!7.44e-08!11;UBERON:0003059!7.44e-08!11;UBERON:0007282!7.44e-08!11;UBERON:0009618!7.44e-08!11;UBERON:0007285!7.44e-08!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001044,2.06e-13,1;UBERON:0001736,2.06e-13,1;UBERON:0003293,2.06e-13,1;UBERON:0003294,2.06e-13,1;UBERON:0001829,2.06e-13,1;UBERON:0010047,2.06e-13,1;UBERON:0000167,2.06e-13,1;UBERON:0006298,2.06e-13,1;UBERON:0001134,4.50e-13,9;UBERON:0002036,4.50e-13,9;UBERON:0002385,4.50e-13,9;UBERON:0000486,4.50e-13,9;UBERON:0007503,4.50e-13,9;UBERON:0001015,4.50e-13,9;UBERON:0002329,4.50e-13,9;UBERON:0003082,4.50e-13,9;UBERON:0003059,4.50e-13,9;UBERON:0007282,4.50e-13,9;UBERON:0004290,4.50e-13,9;UBERON:0009618,4.50e-13,9;UBERON:0000383,7.70e-12,10;UBERON:0007524,7.91e-11,11;UBERON:0003077,7.91e-11,11;UBERON:0007285,7.91e-11,11;UBERON:0000165,2.35e-07,2;UBERON:0000166,2.35e-07,2;UBERON:0000930,2.35e-07,2 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.27797446105362,7.813353445238,4.18818995179039,21.7645650571475,10.9287277593351,8.25367600152961,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201683524623343,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24267862617385,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr1:39495912..39495928,- | |||
}} | |||
Latest revision as of 15:31, 5 August 2015
| Short description: | p@chr1:39495912..39495928, - |
|---|---|
| Species: | Mouse (Mus musculus) |
| DPI dataset: | NA |
| TSS-like-by-RIKEN-classifier(Yes/No): | NA |
| DHS support(Yes/No): | NA |
| Description: | CAGE_peak_at_chr1:39495912..39495928, - |
| Coexpression cluster: | MCL_coexpression_mm9:6 |
| Association with transcript: | NA |
| EntrezGene: | NA |
| Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| multi-potent skeletal muscle stem cell | 4.50e-13 | 9 |
| Ontology term | p-value | n |
|---|---|---|
| saliva-secreting gland | 2.06e-13 | 1 |
| submandibular gland | 2.06e-13 | 1 |
| gland of oral region | 2.06e-13 | 1 |
| gland of foregut | 2.06e-13 | 1 |
| major salivary gland | 2.06e-13 | 1 |
| oral gland | 2.06e-13 | 1 |
| oral cavity | 2.06e-13 | 1 |
| submandibular gland primordium | 2.06e-13 | 1 |
| skeletal muscle tissue | 4.50e-13 | 9 |
| striated muscle tissue | 4.50e-13 | 9 |
| muscle tissue | 4.50e-13 | 9 |
| multilaminar epithelium | 4.50e-13 | 9 |
| epithelial vesicle | 4.50e-13 | 9 |
| musculature | 4.50e-13 | 9 |
| somite | 4.50e-13 | 9 |
| myotome | 4.50e-13 | 9 |
| presomitic mesoderm | 4.50e-13 | 9 |
| presumptive segmental plate | 4.50e-13 | 9 |
| dermomyotome | 4.50e-13 | 9 |
| trunk paraxial mesoderm | 4.50e-13 | 9 |
| musculature of body | 7.70e-12 | 10 |
| dense mesenchyme tissue | 7.91e-11 | 11 |
| paraxial mesoderm | 7.91e-11 | 11 |
| presumptive paraxial mesoderm | 7.91e-11 | 11 |
| mouth | 2.35e-07 | 2 |
| oral opening | 2.35e-07 | 2 |
| stomodeum | 2.35e-07 | 2 |
| Ontology term | p-value | n |
|---|---|---|
| musculoskeletal system cancer | 1.58e-37 | 3 |
| muscle cancer | 1.58e-37 | 3 |
| organ system cancer | 3.24e-19 | 6 |